Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui He

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Oncotarget|February 10, 2017
Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinomaJunlin Yi, Xiaodong Huang, Zhengang Xu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 19, 2014
Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Mei Dong, et al.
Hematology (Amsterdam, Netherlands)|April 15, 2016
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomasBo Jia, Shaoxuan Hu, Jianliang Yang, et al.
The Lancet. Oncology|September 15, 2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trialsWenfeng Fang, Yunpeng Yang, Yuxiang Ma, et al.
Mbio|April 28, 2021
The Architectural Factor HMGB1 Is Involved in Genome Organization in the Human Malaria Parasite Plasmodium falciparumBinbin Lu, Meng Liu, Liang Gu, et al.
BMC Cancer|November 29, 2022
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trialXi Luo, Xiaodong Huang, Jingwei Luo, et al.
Nature Communications|August 28, 2025
Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatmentXinyu Yu, Jincan He, Changhong Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 27, 2015
Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysisYouwu Shi, Shengyu Zhou, Xiaohui He, et al.
Mbio|June 4, 2020
Rrp6 Regulates Heterochromatic Gene Silencing via ncRNA RUF6 Decay in Malaria ParasitesYanting Fan, Shijun Shen, Guiying Wei, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Suyi Kang, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Oncotarget|February 10, 2017
Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinomaJunlin Yi, Xiaodong Huang, Zhengang Xu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 19, 2014
Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Mei Dong, et al.
Hematology (Amsterdam, Netherlands)|April 15, 2016
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomasBo Jia, Shaoxuan Hu, Jianliang Yang, et al.
The Lancet. Oncology|September 15, 2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trialsWenfeng Fang, Yunpeng Yang, Yuxiang Ma, et al.
Mbio|April 28, 2021
The Architectural Factor HMGB1 Is Involved in Genome Organization in the Human Malaria Parasite Plasmodium falciparumBinbin Lu, Meng Liu, Liang Gu, et al.
BMC Cancer|November 29, 2022
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trialXi Luo, Xiaodong Huang, Jingwei Luo, et al.
Nature Communications|August 28, 2025
Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatmentXinyu Yu, Jincan He, Changhong Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 27, 2015
Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysisYouwu Shi, Shengyu Zhou, Xiaohui He, et al.
Mbio|June 4, 2020
Rrp6 Regulates Heterochromatic Gene Silencing via ncRNA RUF6 Decay in Malaria ParasitesYanting Fan, Shijun Shen, Guiying Wei, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Suyi Kang, et al.
Pageof 20